No record found
No record found
No record found
capitalstake.com. Provided by * Returns not adjusted for payouts
^The historical stock prices have been adjusted to reflect stock splits to ensure comparability over time.
Company Profile
Haleon Pakistan Limited (formerly known as GlaxoSmithKline Consumer Healthcare Pakistan Limited) was incorporated in Pakistan as a public listed company under the provisions of the repealed Companies Ordinance, 1984 (now Companies Act, 2017) on 31 March 2015. The Company is a subsidiary of ‘Haleon Netherlands B.V’. The ultimate parent of the Company is Haleon plc. The Company is inter alia principally engaged in the manufacturing, marketing and sale of consumer healthcare and over the counter health products.
| Qawi Naseer | CEO |
| Farhan Muhammad Haroon | Chairperson |
| Mashal Mohammad | Company Secretary |
11-A, 11th Floor, Sky Tower (East Wing), Dolmen City, HC-3, Block 4, Scheme-5, Clifton, Karachi, 75600
CDC Share Registrar Services Limited CDC House, Main Shahrah-e-Faisal, Karachi.
M/s KPMG Taseer Hadi & Co. Chartered Accountants
December
Equity Profile
Announcements
| Date | Title | Document |
|---|---|---|
| Apr 29, 2026 | Financial Results for the Quarter Ended 31 March 2026 | View PDF |
| Apr 7, 2026 | Transmission of Annual Report for the Year Ended 2025 | View PDF |
| Mar 3, 2026 | Financial Results for the Year Ended 31 December 2025 | View PDF |
| Oct 30, 2025 | Transmission of Quarterly Report for the Period Ended 30 September 2025 | View PDF |
| Oct 27, 2025 | Financial Results for the Quarter Ended 30 September 2025 | View PDF |
| Date | Title | Document |
|---|---|---|
| Apr 28, 2026 | CTC of Resolutions Passed in the Annual General Meeting 2025 | View PDF |
| Apr 21, 2026 | Notice of Board of Directors Meeting - (Q1-2026) | View PDF |
| Apr 7, 2026 | Notice of Annual General Meeting | View PDF |
| Apr 6, 2026 | Prior Publication of Annual General Meeting Notice | View PDF |
| Mar 2, 2026 | Board Meeting In Progress | View PDF |
| Date | Title | Document |
|---|---|---|
| Apr 27, 2026 | Presentation of Corporate Briefing Session YE 2025 | View PDF |
| Apr 23, 2026 | Notice of Corporate Briefing Session YE 2025 | View PDF |
| Jan 27, 2026 | Disclosure of Material Information | View PDF |
| Dec 3, 2025 | Disclosure of Material Information | View PDF |
| Nov 19, 2025 | Presentation for Corporate Briefing Session 2025 | View PDF |
Financials
All numbers in thousands (000's) except EPS
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 43,106,420 | 37,205,893 | 31,609,776 | 27,507,212 |
| Profit after Taxation | 6,373,151 | 4,578,247 | 995,586 | 325,411 |
| EPS | 54.45 | 39.11 | 8.51 | 2.78 |
| Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | |
|---|---|---|---|---|
| Sales | 10,562,883 | 11,598,087 | 10,029,843 | 9,754,500 |
| Profit after Taxation | 1,615,006 | 1,623,159 | 1,347,596 | 1,329,784 |
| EPS | 13.80 | 13.87 | 11.51 | 11.36 |

Ratios
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Gross Profit Margin (%) | 39.09 | 34.45 | 20.40 | 17.40 |
| Net Profit Margin (%) | 14.78 | 12.31 | 3.15 | 1.18 |
| EPS Growth (%) | 39.22 | 359.58 | 206.12 | (84.75) |
| PEG | 0.39 | 0.06 | 0.10 | (0.70) |










Feedback
Terms of Use
https://www.psx.com.pk